Animals given the experimental therapy survived twice as long as untreated counterparts.
The preferred management of patients with recurrent platinum-sensitive ovarian cancer (PSOC) is platinum-based doublet therapy with selective ...
In a promising development for cancer treatment, a collaborative research team has overcome two issues that have prevented photothermal therapy, a much less invasive treatment option than surgery ...
A new cancer diagnostic test marketed by Veracyte and developed by a group of researchers, including UNC geneticist Charles Perou, Ph.D., has been found to accurately predict whether patients with ...
Between hospital appointments, treatment and the sudden disorientation of a life reorganised around illness, many don’t know ...
Several types of cancer are triggered by mutations in a protein called BRAF. Researchers at the Paul Scherrer Institute PSI ...
In a phase 2 clinical trial, Mass General Brigham Cancer Institute researchers found that the oral drug avatrombopag was safe ...
A new Channel 4 series has shed light on the "groundbreaking" research being conducted in the field of cancer treatment and management. The three-part series, Cancer Detectives: Finding the Cures, ...
Ovarian cancer patients and oncologists are sounding the alarm about a lack of treatment options, and are hoping country's ...
When you have cancer, staying connected with family and friends isn’t always easy. Whether you’re in active treatment, on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results